0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Muscle Relaxers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-26Z1723
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Muscle Relaxers Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Muscle Relaxers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-26Z1723
Report
October 2024
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Muscle Relaxers - Market Size

The global market for Muscle Relaxers was estimated to be worth US$ 3740 million in 2023 and is forecast to a readjusted size of US$ 5065.3 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030

Muscle Relaxers - Market

Muscle Relaxers - Market

Muscle relaxers are a group of drugs that have a sedative effect and may be prescribed for back, neck, and other musculoskeletal pain.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth. For instance, 1 in 6 people worldwide will be 60 or older by 2030. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to triple, reaching 426 million.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Muscle Relaxers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Muscle Relaxers by region & country, by Type, and by Application.
The Muscle Relaxers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle Relaxers.
Market Segmentation

Scope of Muscle Relaxers - Market Report

Report Metric Details
Report Name Muscle Relaxers - Market
Forecasted market size in 2030 US$ 5065.3 million
CAGR 4.4%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Allergan, Ipsen Group, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical, Merz Pharma, Mylan, Fresenius Kabi, Endo International, Par Sterile Products, Acorda Therapeutics, SteriMax Inc, Emcure Pharmaceuticals, Upsher-Smith Laboratories, Orient Pharma, Daewoong Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Muscle Relaxers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Muscle Relaxers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Muscle Relaxers in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Muscle Relaxers - Market size in 2030?

Ans: The Muscle Relaxers - Market size in 2030 will be US$ 5065.3 million.

Who are the main players in the Muscle Relaxers - Market report?

Ans: The main players in the Muscle Relaxers - Market are Pfizer, Allergan, Ipsen Group, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical, Merz Pharma, Mylan, Fresenius Kabi, Endo International, Par Sterile Products, Acorda Therapeutics, SteriMax Inc, Emcure Pharmaceuticals, Upsher-Smith Laboratories, Orient Pharma, Daewoong Pharmaceutical

What are the Application segmentation covered in the Muscle Relaxers - Market report?

Ans: The Applications covered in the Muscle Relaxers - Market report are Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

What are the Type segmentation covered in the Muscle Relaxers - Market report?

Ans: The Types covered in the Muscle Relaxers - Market report are Methocarbamol, Cyclobenzaprine, Tizanidine, Baclofen, Others

Recommended Reports

Muscle Disease Drugs

Muscle Pain & Relief

Muscle Therapy Devices

1 Market Overview
1.1 Muscle Relaxers Product Introduction
1.2 Global Muscle Relaxers Market Size Forecast
1.3 Muscle Relaxers Market Trends & Drivers
1.3.1 Muscle Relaxers Industry Trends
1.3.2 Muscle Relaxers Market Drivers & Opportunity
1.3.3 Muscle Relaxers Market Challenges
1.3.4 Muscle Relaxers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Muscle Relaxers Players Revenue Ranking (2023)
2.2 Global Muscle Relaxers Revenue by Company (2019-2024)
2.3 Key Companies Muscle Relaxers Manufacturing Base Distribution and Headquarters
2.4 Key Companies Muscle Relaxers Product Offered
2.5 Key Companies Time to Begin Mass Production of Muscle Relaxers
2.6 Muscle Relaxers Market Competitive Analysis
2.6.1 Muscle Relaxers Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Muscle Relaxers Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Methocarbamol
3.1.2 Cyclobenzaprine
3.1.3 Tizanidine
3.1.4 Baclofen
3.1.5 Others
3.2 Global Muscle Relaxers Sales Value by Type
3.2.1 Global Muscle Relaxers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Muscle Relaxers Sales Value, by Type (2019-2030)
3.2.3 Global Muscle Relaxers Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Online Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Hospital Pharmacies
4.2 Global Muscle Relaxers Sales Value by Application
4.2.1 Global Muscle Relaxers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Muscle Relaxers Sales Value, by Application (2019-2030)
4.2.3 Global Muscle Relaxers Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Muscle Relaxers Sales Value by Region
5.1.1 Global Muscle Relaxers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Muscle Relaxers Sales Value by Region (2019-2024)
5.1.3 Global Muscle Relaxers Sales Value by Region (2025-2030)
5.1.4 Global Muscle Relaxers Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Muscle Relaxers Sales Value, 2019-2030
5.2.2 North America Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Muscle Relaxers Sales Value, 2019-2030
5.3.2 Europe Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Muscle Relaxers Sales Value, 2019-2030
5.4.2 Asia Pacific Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Muscle Relaxers Sales Value, 2019-2030
5.5.2 South America Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Muscle Relaxers Sales Value, 2019-2030
5.6.2 Middle East & Africa Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Muscle Relaxers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Muscle Relaxers Sales Value
6.3 United States
6.3.1 United States Muscle Relaxers Sales Value, 2019-2030
6.3.2 United States Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Muscle Relaxers Sales Value, 2019-2030
6.4.2 Europe Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Muscle Relaxers Sales Value, 2019-2030
6.5.2 China Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Muscle Relaxers Sales Value, 2019-2030
6.6.2 Japan Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Muscle Relaxers Sales Value, 2019-2030
6.7.2 South Korea Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Muscle Relaxers Sales Value, 2019-2030
6.8.2 Southeast Asia Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Muscle Relaxers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Muscle Relaxers Sales Value, 2019-2030
6.9.2 India Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Muscle Relaxers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Muscle Relaxers Products, Services and Solutions
7.1.4 Pfizer Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Allergan
7.2.1 Allergan Profile
7.2.2 Allergan Main Business
7.2.3 Allergan Muscle Relaxers Products, Services and Solutions
7.2.4 Allergan Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.2.5 Allergan Recent Developments
7.3 Ipsen Group
7.3.1 Ipsen Group Profile
7.3.2 Ipsen Group Main Business
7.3.3 Ipsen Group Muscle Relaxers Products, Services and Solutions
7.3.4 Ipsen Group Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.3.5 Teva Pharmaceuticals Recent Developments
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Profile
7.4.2 Teva Pharmaceuticals Main Business
7.4.3 Teva Pharmaceuticals Muscle Relaxers Products, Services and Solutions
7.4.4 Teva Pharmaceuticals Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.4.5 Teva Pharmaceuticals Recent Developments
7.5 Novartis
7.5.1 Novartis Profile
7.5.2 Novartis Main Business
7.5.3 Novartis Muscle Relaxers Products, Services and Solutions
7.5.4 Novartis Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.5.5 Novartis Recent Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Profile
7.6.2 Johnson & Johnson Main Business
7.6.3 Johnson & Johnson Muscle Relaxers Products, Services and Solutions
7.6.4 Johnson & Johnson Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.6.5 Johnson & Johnson Recent Developments
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Profile
7.7.2 Takeda Pharmaceutical Main Business
7.7.3 Takeda Pharmaceutical Muscle Relaxers Products, Services and Solutions
7.7.4 Takeda Pharmaceutical Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.7.5 Takeda Pharmaceutical Recent Developments
7.8 Sun Pharmaceutical
7.8.1 Sun Pharmaceutical Profile
7.8.2 Sun Pharmaceutical Main Business
7.8.3 Sun Pharmaceutical Muscle Relaxers Products, Services and Solutions
7.8.4 Sun Pharmaceutical Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.8.5 Sun Pharmaceutical Recent Developments
7.9 Merz Pharma
7.9.1 Merz Pharma Profile
7.9.2 Merz Pharma Main Business
7.9.3 Merz Pharma Muscle Relaxers Products, Services and Solutions
7.9.4 Merz Pharma Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.9.5 Merz Pharma Recent Developments
7.10 Mylan
7.10.1 Mylan Profile
7.10.2 Mylan Main Business
7.10.3 Mylan Muscle Relaxers Products, Services and Solutions
7.10.4 Mylan Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.10.5 Mylan Recent Developments
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Profile
7.11.2 Fresenius Kabi Main Business
7.11.3 Fresenius Kabi Muscle Relaxers Products, Services and Solutions
7.11.4 Fresenius Kabi Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.11.5 Fresenius Kabi Recent Developments
7.12 Endo International
7.12.1 Endo International Profile
7.12.2 Endo International Main Business
7.12.3 Endo International Muscle Relaxers Products, Services and Solutions
7.12.4 Endo International Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.12.5 Endo International Recent Developments
7.13 Par Sterile Products
7.13.1 Par Sterile Products Profile
7.13.2 Par Sterile Products Main Business
7.13.3 Par Sterile Products Muscle Relaxers Products, Services and Solutions
7.13.4 Par Sterile Products Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.13.5 Par Sterile Products Recent Developments
7.14 Acorda Therapeutics
7.14.1 Acorda Therapeutics Profile
7.14.2 Acorda Therapeutics Main Business
7.14.3 Acorda Therapeutics Muscle Relaxers Products, Services and Solutions
7.14.4 Acorda Therapeutics Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.14.5 Acorda Therapeutics Recent Developments
7.15 SteriMax Inc
7.15.1 SteriMax Inc Profile
7.15.2 SteriMax Inc Main Business
7.15.3 SteriMax Inc Muscle Relaxers Products, Services and Solutions
7.15.4 SteriMax Inc Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.15.5 SteriMax Inc Recent Developments
7.16 Emcure Pharmaceuticals
7.16.1 Emcure Pharmaceuticals Profile
7.16.2 Emcure Pharmaceuticals Main Business
7.16.3 Emcure Pharmaceuticals Muscle Relaxers Products, Services and Solutions
7.16.4 Emcure Pharmaceuticals Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.16.5 Emcure Pharmaceuticals Recent Developments
7.17 Upsher-Smith Laboratories
7.17.1 Upsher-Smith Laboratories Profile
7.17.2 Upsher-Smith Laboratories Main Business
7.17.3 Upsher-Smith Laboratories Muscle Relaxers Products, Services and Solutions
7.17.4 Upsher-Smith Laboratories Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.17.5 Upsher-Smith Laboratories Recent Developments
7.18 Orient Pharma
7.18.1 Orient Pharma Profile
7.18.2 Orient Pharma Main Business
7.18.3 Orient Pharma Muscle Relaxers Products, Services and Solutions
7.18.4 Orient Pharma Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.18.5 Orient Pharma Recent Developments
7.19 Daewoong Pharmaceutical
7.19.1 Daewoong Pharmaceutical Profile
7.19.2 Daewoong Pharmaceutical Main Business
7.19.3 Daewoong Pharmaceutical Muscle Relaxers Products, Services and Solutions
7.19.4 Daewoong Pharmaceutical Muscle Relaxers Revenue (US$ Million) & (2019-2024)
7.19.5 Daewoong Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Muscle Relaxers Industrial Chain
8.2 Muscle Relaxers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Muscle Relaxers Sales Model
8.5.2 Sales Channel
8.5.3 Muscle Relaxers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Muscle Relaxers Market Trends
    Table 2. Muscle Relaxers Market Drivers & Opportunity
    Table 3. Muscle Relaxers Market Challenges
    Table 4. Muscle Relaxers Market Restraints
    Table 5. Global Muscle Relaxers Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Muscle Relaxers Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Muscle Relaxers Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Muscle Relaxers Product Type
    Table 9. Key Companies Time to Begin Mass Production of Muscle Relaxers
    Table 10. Global Muscle Relaxers Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Muscle Relaxers Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Muscle Relaxers Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Muscle Relaxers Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Muscle Relaxers Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Muscle Relaxers Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Muscle Relaxers Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Muscle Relaxers Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Muscle Relaxers Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Muscle Relaxers Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Muscle Relaxers Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Muscle Relaxers Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Muscle Relaxers Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Muscle Relaxers Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Muscle Relaxers Sales Value by Region (2019-2024) & (%)
    Table 27. Global Muscle Relaxers Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Muscle Relaxers Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Muscle Relaxers Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Muscle Relaxers Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Muscle Relaxers Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Muscle Relaxers Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. Allergan Basic Information List
    Table 37. Allergan Description and Business Overview
    Table 38. Allergan Muscle Relaxers Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Muscle Relaxers Business of Allergan (2019-2024)
    Table 40. Allergan Recent Developments
    Table 41. Ipsen Group Basic Information List
    Table 42. Ipsen Group Description and Business Overview
    Table 43. Ipsen Group Muscle Relaxers Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Muscle Relaxers Business of Ipsen Group (2019-2024)
    Table 45. Ipsen Group Recent Developments
    Table 46. Teva Pharmaceuticals Basic Information List
    Table 47. Teva Pharmaceuticals Description and Business Overview
    Table 48. Teva Pharmaceuticals Muscle Relaxers Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Muscle Relaxers Business of Teva Pharmaceuticals (2019-2024)
    Table 50. Teva Pharmaceuticals Recent Developments
    Table 51. Novartis Basic Information List
    Table 52. Novartis Description and Business Overview
    Table 53. Novartis Muscle Relaxers Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Muscle Relaxers Business of Novartis (2019-2024)
    Table 55. Novartis Recent Developments
    Table 56. Johnson & Johnson Basic Information List
    Table 57. Johnson & Johnson Description and Business Overview
    Table 58. Johnson & Johnson Muscle Relaxers Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Muscle Relaxers Business of Johnson & Johnson (2019-2024)
    Table 60. Johnson & Johnson Recent Developments
    Table 61. Takeda Pharmaceutical Basic Information List
    Table 62. Takeda Pharmaceutical Description and Business Overview
    Table 63. Takeda Pharmaceutical Muscle Relaxers Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Muscle Relaxers Business of Takeda Pharmaceutical (2019-2024)
    Table 65. Takeda Pharmaceutical Recent Developments
    Table 66. Sun Pharmaceutical Basic Information List
    Table 67. Sun Pharmaceutical Description and Business Overview
    Table 68. Sun Pharmaceutical Muscle Relaxers Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Muscle Relaxers Business of Sun Pharmaceutical (2019-2024)
    Table 70. Sun Pharmaceutical Recent Developments
    Table 71. Merz Pharma Basic Information List
    Table 72. Merz Pharma Description and Business Overview
    Table 73. Merz Pharma Muscle Relaxers Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Muscle Relaxers Business of Merz Pharma (2019-2024)
    Table 75. Merz Pharma Recent Developments
    Table 76. Mylan Basic Information List
    Table 77. Mylan Description and Business Overview
    Table 78. Mylan Muscle Relaxers Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Muscle Relaxers Business of Mylan (2019-2024)
    Table 80. Mylan Recent Developments
    Table 81. Fresenius Kabi Basic Information List
    Table 82. Fresenius Kabi Description and Business Overview
    Table 83. Fresenius Kabi Muscle Relaxers Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Muscle Relaxers Business of Fresenius Kabi (2019-2024)
    Table 85. Fresenius Kabi Recent Developments
    Table 86. Endo International Basic Information List
    Table 87. Endo International Description and Business Overview
    Table 88. Endo International Muscle Relaxers Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Muscle Relaxers Business of Endo International (2019-2024)
    Table 90. Endo International Recent Developments
    Table 91. Par Sterile Products Basic Information List
    Table 92. Par Sterile Products Description and Business Overview
    Table 93. Par Sterile Products Muscle Relaxers Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Muscle Relaxers Business of Par Sterile Products (2019-2024)
    Table 95. Par Sterile Products Recent Developments
    Table 96. Acorda Therapeutics Basic Information List
    Table 97. Acorda Therapeutics Description and Business Overview
    Table 98. Acorda Therapeutics Muscle Relaxers Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Muscle Relaxers Business of Acorda Therapeutics (2019-2024)
    Table 100. Acorda Therapeutics Recent Developments
    Table 101. SteriMax Inc Basic Information List
    Table 102. SteriMax Inc Description and Business Overview
    Table 103. SteriMax Inc Muscle Relaxers Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Muscle Relaxers Business of SteriMax Inc (2019-2024)
    Table 105. SteriMax Inc Recent Developments
    Table 106. Emcure Pharmaceuticals Basic Information List
    Table 107. Emcure Pharmaceuticals Description and Business Overview
    Table 108. Emcure Pharmaceuticals Muscle Relaxers Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Muscle Relaxers Business of Emcure Pharmaceuticals (2019-2024)
    Table 110. Emcure Pharmaceuticals Recent Developments
    Table 111. Upsher-Smith Laboratories Basic Information List
    Table 112. Upsher-Smith Laboratories Description and Business Overview
    Table 113. Upsher-Smith Laboratories Muscle Relaxers Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Muscle Relaxers Business of Upsher-Smith Laboratories (2019-2024)
    Table 115. Upsher-Smith Laboratories Recent Developments
    Table 116. Orient Pharma Basic Information List
    Table 117. Orient Pharma Description and Business Overview
    Table 118. Orient Pharma Muscle Relaxers Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Muscle Relaxers Business of Orient Pharma (2019-2024)
    Table 120. Orient Pharma Recent Developments
    Table 121. Daewoong Pharmaceutical Basic Information List
    Table 122. Daewoong Pharmaceutical Description and Business Overview
    Table 123. Daewoong Pharmaceutical Muscle Relaxers Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Muscle Relaxers Business of Daewoong Pharmaceutical (2019-2024)
    Table 125. Daewoong Pharmaceutical Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. Muscle Relaxers Downstream Customers
    Table 129. Muscle Relaxers Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Muscle Relaxers Product Picture
    Figure 2. Global Muscle Relaxers Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Muscle Relaxers Sales Value (2019-2030) & (US$ Million)
    Figure 4. Muscle Relaxers Report Years Considered
    Figure 5. Global Muscle Relaxers Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Muscle Relaxers Revenue in 2023
    Figure 7. Muscle Relaxers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Methocarbamol Picture
    Figure 9. Cyclobenzaprine Picture
    Figure 10. Tizanidine Picture
    Figure 11. Baclofen Picture
    Figure 12. Others Picture
    Figure 13. Global Muscle Relaxers Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Muscle Relaxers Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Online Pharmacies
    Figure 16. Product Picture of Retail Pharmacies
    Figure 17. Product Picture of Hospital Pharmacies
    Figure 18. Global Muscle Relaxers Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Muscle Relaxers Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Muscle Relaxers Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Muscle Relaxers Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Muscle Relaxers Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Muscle Relaxers Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Muscle Relaxers Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Muscle Relaxers Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Muscle Relaxers Sales Value (%), (2019-2030)
    Figure 31. United States Muscle Relaxers Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Muscle Relaxers Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Muscle Relaxers Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Muscle Relaxers Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Muscle Relaxers Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Muscle Relaxers Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Muscle Relaxers Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Muscle Relaxers Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Muscle Relaxers Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Muscle Relaxers Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Muscle Relaxers Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Muscle Relaxers Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Muscle Relaxers Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Muscle Relaxers Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Muscle Relaxers Sales Value by Application (%), 2023 VS 2030
    Figure 52. Muscle Relaxers Industrial Chain
    Figure 53. Muscle Relaxers Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS